Summary
Updated Aug 31, 2026
Myron Z. Holubiak is Secretary, Director of CITIUS ONCOLOGY, INC. (CTOR). 6 SEC Form 4 filings on record going back to 2024, most recently on 22 December 2025.
Recent Transactions
4Every recent SEC Form 4 transaction Myron Z. Holubiak has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Myron Z. Holubiak's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Martine A. Rothblatt - $703.37M of UTHR open-market activity in the last 12 months
- Ronda E. Stryker - $580.89M of SYK open-market activity in the last 12 months
- Keith A. Meister - $533.93M of ILMN open-market activity in the last 12 months
- TPG GP A, LLC - $516.71M of LFST open-market activity in the last 12 months
- BERKSHIRE HATHAWAY INC - $473.67M of DVA open-market activity in the last 12 months
- Fairmount Funds Management LLC - $399.66M of SYRE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Myron Z. Holubiak?
Myron Z. Holubiak is a corporate insider, tracked as Secretary, Director of CITIUS ONCOLOGY, INC. (CTOR). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Myron Z. Holubiak last file a Form 4?
The most recent primary Form 4 on record is dated 22 December 2025, one of 6 filings going back to 2024.
Where can I see all of Myron Z. Holubiak's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Myron Z. Holubiak and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
